HENRY SCHEIN INC
$75.36
+0.68%
Henry Schein reported Q4 2025 revenue of $3.44B (+7.7% YoY), beating the $3.34B estimate, with EPS of $1.34 topping the $1.30 consensus by $0.04. The company set FY2026 guidance at $5.23-$5.37 EPS, and the consensus analyst recommendation is "Hold" with 13 analysts covering the stock and an average 12-month target of $85.58. The stock recently dipped to $75.57 following post-earnings retreat, though near-term catalysts remain supportive of the dental supply and distribution business.